Ranbaxy puts in bid for Merck's generic unit
India's biggest drug maker Ranbaxy Laboratories Ltd has put in its bid to acquire generic business of German pharmaceutical firm Merck.
By PTI |
NEW DELHI: India's biggest drug maker Ranbaxy Laboratories Ltd has put in its bid to acquire generic business of German pharmaceutical firm Merck.
Industry sources said the company had put in its bid yesterday for acquiring Merck KGaA's generic business, which is estimated to be valued around six billion dollars.
The Gurgaon-based company has appointed Goldman Sachs and Citigroup as its managers for the deal, sources said.
Merck is the fourth biggest generic drug manufacturer in the world for which Novartis AG, Stada Arzneimittel AG and Teva are reportedly to be in the race.
The German company is hiving of its generic unit to concentrate on branded formulations.
Earlier, other Indian companies including Dr Reddy's Laboratories were also in the race but it had pulled out.
Ranbaxy's shares fell 1.56 per cent to Rs 318.75 on the Bombay Stock Exchange.
Industry sources said the company had put in its bid yesterday for acquiring Merck KGaA's generic business, which is estimated to be valued around six billion dollars.
The Gurgaon-based company has appointed Goldman Sachs and Citigroup as its managers for the deal, sources said.
Merck is the fourth biggest generic drug manufacturer in the world for which Novartis AG, Stada Arzneimittel AG and Teva are reportedly to be in the race.
The German company is hiving of its generic unit to concentrate on branded formulations.
Earlier, other Indian companies including Dr Reddy's Laboratories were also in the race but it had pulled out.
ADVERTISEMENT
Ranbaxy's shares fell 1.56 per cent to Rs 318.75 on the Bombay Stock Exchange.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
